New clinical trial – capsaicin nanoparticles in patients with painful diabetic neuropathy


Mahidol University and the Thailand Research Fund recently started a phase II/III clinical trial involving a capsaicin nanoparticle preparation, now registered in the Clinicaltrials.gov database under reference NCT01125215. According to this page, the aim is to “determine efficacy and safety of 0.75% topical capsaicin nanoparticle preparation versus placebo in patient with painful diabetic neuropathy“. The study is currently recruiting participants.

Advertisements